Top

Published in:

01-11-2008 | ssat poster presentation

TGF-β1 and IGF-1 and Anastomotic Recurrence of Crohn’s Disease After Ileo-Colonic Resection

Authors: Marco Scarpa, Marina Bortolami, Susan L. Morgan, Andromachi Kotsafti, Cesare Ruffolo, Renata D’Incà, Eugenia Bertin, Lino Polese, Davide F. D’Amico, Giacomo C. Sturniolo, Imerio Angriman

Published in: Journal of Gastrointestinal Surgery | Issue 11/2008

Abstract

Background

After bowel resection, Crohn’s disease (CD) recurs frequently in the site of the anastomosis. Alteration of normal healing processes may play a role in this phenomenon. Transforming growth factor beta (TGF-β) and insulin-like growth factor (IGF-1) are involved in wound healing mechanisms with pro-fibrogenic properties. The aim of this study was to assess the expression of TGF-β1 and insulin-like growth factor 1 (IGF-1) in the different zones of the bowel wall to understand why side-to-side anastomosis are associated to a lower recurrence rate compared to end-to-end ones.

Patients and Methods

Seventeen patients affected by CD who underwent ileo-colonic resection from 2004 to 2005 were enrolled in this study. Full-thickness tissue samples were obtained from the mesenteric, the lateral, and the anti-mesenteric sides of the macroscopically diseased and healthy ileum for each patient. TGF-β1 and IGF-1 messenger RNAs (mRNAs) were quantified by real-time polymerase chain reaction. Myeloperoxidase activity and histological disease activity were assessed to quantify the ileal inflammation. Vimentin, desmin, and α-smooth muscle actin were stained with immunohistochemistry to assess the fibroblast, smooth muscle cell, and myofibroblasts populations. Comparisons and correlations were carried out with nonparametric tests.

Results

In diseased ileum, TGF-β1 mRNA transcripts in the antimesenteric side were significantly lower than those of the mesenteric side (p = 0.05), and a significant correlation between TGFβ-1 levels in diseased bowel and the sampling site was observed (τ = 0.36, p = 0.03). On the contrary, neither the IGF-1 mRNA transcripts nor the distribution of fibroblast, smooth muscle cell, and myofibroblasts populations showed any relation with the sampling site.

Conclusion

TGF-β1 mRNA expression was lower in the anti-mesenteric side of the diseased ileum, and this was consistent with the success of side-to-side anastomosis in preventing CD recurrence. Since high expression of TGF-β1 was associated to early recurrence, it seems rationale to construct the anastomosis on the anti-mesenteric side of the bowel.

Williams JG, Wong WD, Rothenberger DA, Goldberg SM. Recurrence of Crohn’s disease after resection. Br J Surg 1991;78:10–19. doi:10.1002/bjs.1800780106.PubMedCrossRef

Tytgat GNJ, Mulder GJI, Brummerlkamp WH. Endoscopic lesion in Crohn’s disease early after ileocecal resection. Endoscopy 1988;20:260–262.PubMedCrossRef

Wolff BG. Factors determining recurrence following surgery for Crohn’s disease. World J Surg 1998;22:364–369. doi:10.1007/s002689900398.PubMedCrossRef

Boreley NR, Mortensen NJ, Jewell DP. Preventing postoperative recurrence of Crohn’s disease. Br J Surg 1997;84(11):1493–1502. doi:10.1002/bjs.1800841104.CrossRef

Moskovitz D, McLeod RS, Greenberg GR, Cohen Z. Operative and environmental risk factors for recurrence of Crohn’s disease. Int J Colorectal Dis 1999;14(4–5):224–226. doi:10.1007/s003840050215.PubMedCrossRef

Scott NA, Sue-Ling HM, Hughes LE. Anastomotic configuration does not affect recurrence of Crohn’s disease after ileo-colonic resection. Int J Colorectal Dis 1995;10:67–69. doi:10.1007/BF00341197.PubMedCrossRef

Cameron JL, Hamilton SR, Coleman J, Sitzmann JV, Bayless TM. Patterns of ileal recurrence in Crohn’s disease. A prospective randomized study. Ann Surg 1992;215(5):546–551. doi:10.1097/00000658-199205000-00018.PubMedCrossRef

Hashemi M, Novell JR, Lewis AA. Side-to-side anastomosis may delay recurrence in Crohn’s disease. Dis Colon Rectum 1998;41(10):1293–1296. doi:10.1007/BF02258231.PubMedCrossRef

Yamamoto T, Bain IM, Mylonakis E, Allan RN, Keighley MRB. Stapled functional end-to-end anastomosis versus sutured end-to-end anastomosis after ileocolonic resection in Crohn’s disease. Scand J Gastroenterol 1999;7:708–713. doi:10.1080/003655299750025921.CrossRef

10.

Ikeuchi H, Kusunoki M, Yamamura T. Long term results of stapled and hand sewn anastomosis in patients with Crohn’s disease. Dig Surg 2000;17(5):493–496. doi:10.1159/000051946.PubMedCrossRef

11.

Munoz-Juarez M, Yamamoto T, Wolff BG, Keighley MRB. Wide-lumen stapled anastomosis versus conventional end-to-end anastomosis in the treatment of Crohn’s disease. Dis Colon Rectum 2001;44(1):20–25. doi:10.1007/BF02234814.PubMedCrossRef

12.

Scott AD, Uff C, Phillips RK. Suppression of macrophage function by suture materials and anastomotic recurrence of Crohn’s disease. Br J Surg 1993;80:387–391. doi:10.1002/bjs.1800800342.PubMedCrossRef

13.

Osborne MJ, Hudson M, Piasecki C, Dhillon AP, Lewis AAM, Pounder RE et al. Crohn’s disease and anastomotic recurrence microvascular ischemia and anastomotic healing in an animal model. Br J Surg 1993;80:226–229. doi:10.1002/bjs.1800800236.PubMedCrossRef

14.

Scarpa M, Angriman I, Barollo M, Polese L, Ruffolo C, Bertin M et al. Role of stapled and hand-sewn anastomoses in recurrence of Crohn’s disease. Hepatogastroenterology 2004;51(58):1053–1057.PubMed

15.

Scarpa M, Ruffolo C, Bertin E, Polese L, Filosa T, Prando D et al. Surgical predictors of recurrences of Crohn’s disease after ileocolonic resection. Int J Colorectal Dis 2007;22(9):1061–1069. doi:10.1007/s00384-007-0329-4.PubMedCrossRef

16.

Del Zotto B, Mumolo G, Pronio AM, Montesani C, Tersigni R, Boirivant M. TGF-b1 production in inflammatory bowel disease: differing production patterns in Crohn’s disease and ulcerative colitis. Clin Exp Immunol 2003;134:120–126. doi:10.1046/j.1365-2249.2003.02250.x.PubMedCrossRef

17.

Massague J. Transforming growth factor beta. Annu Rev Cell Biol 1990;6:597–646. doi:10.1146/annurev.cb.06.110190.003121.PubMedCrossRef

18.

Walia B, Wang L, Merlin D. Sitaraman TGF-beta down-regulates IL-6 signalling in intestinal epithelial cells: critical role of SMAD-2. FASEB J 2003;17(14):2130–2132.PubMed

19.

Scarpa M, Bortolami M, Morgan SL, Kotsafti A, Ferraro S, Ruffolo C et al. TGF-b1 and IGF-1 production and recurrence of Crohn’s disease after ileo-colonic resection. J Surg Res 2008; in press.doi:10.1016/j.jss.2008.04.014.

20.

Theiss AL, Fruchtman S, Lund PK. Growth factors in inflammatory bowel disease the actions and interactions of growth hormone and insulin-like growth factor-I. Inflamm Bowel Dis 2004;10:871–880. doi:10.1097/00054725-200411000-00021.PubMedCrossRef

21.

El Yafi F, Winkler R, Delvenne P, Boussif N, Belaiche J, Louis E. Altered expression of type I insulin-like growth factor receptor in Crohn’s disease. Clin Exp Immunol 2005;139:526–533. doi:10.1111/j.1365-2249.2004.02724.x.PubMedCrossRef

22.

Simmons JG, Pucilowska JB, Keku TK, Lund PK. IGF-1 and TGF-b1 have distinct effects on phenotype and proliferation of intestinal fibroblasts. Am J Physiol Gastrointest Liver Physiol 2002;283:G809–G818.PubMed

23.

Harvey RF, Bradshaw JM. A simple index of Crohn’s disease activity. Lancet 1980;1:514. doi:10.1016/S0140-6736(80)92767-1.PubMedCrossRef

24.

Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003;98(6):1309–1314. doi:10.1111/j.1572-0241.2003.07458.x.PubMedCrossRef

25.

Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156–159. doi:10.1016/0003-2697(87)90021-2.PubMedCrossRef

26.

Pucilowska JB, Williams KL, Lund PK. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. Am J Physiol Gastrointest Liver Physiol 2000;279:G653–G659.PubMed

27.

La JH, Kim TW, Sung TS, Kang JW, Kim HJ, Yang IS. Visceral hypersensitivity and altered colonic motility after subsidence of inflammation in a rat model of colitis. World J Gastroenterol 2003;9(12):2791–2795.PubMed

28.

Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344–1350.PubMed

29.

Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 1996;110(4):975–984. doi:10.1053/gast.1996.v110.pm8613031.PubMedCrossRef

30.

Di Mola FF, Friess H, Scheuren A, Di Sebastiano P, Graber H, Egger B et al. Transforming growth factor-bs and their signaling receptors are coexpressed in Crohn’s disease. Ann Surg 1999;229(1):67–75. doi:10.1097/00000658-199901000-00009.PubMedCrossRef

31.

32.

Monteleone G, Del Vecchio Blanco G, Monteleone I, Fina D, Caruso R, Gioia V et al. Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease. Gastroenterology 2005;129(5):1420–1429. doi:10.1053/j.gastro.2005.09.005.PubMedCrossRef

33.

Monteleone G, Mann J, Monteleone I, Vavassori P, Bremner R, Fantini M et al. A failure of transforming growth factor-b1 negative regulation maintains sustained NF-kB activation in gut inflammation. J Biol Chem 2004;279(6):3925–3932. doi:10.1074/jbc.M303654200.PubMedCrossRef

34.

Stallmach A, Schuppan D, Riese HH, Matthes H, Riecken EO. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn’s disease. Gastroenterology 1992;102(6):1920–1929.PubMed

35.

Zimmermann EM, Li L, Hou YT, Mohapatra NK, Pucilowska JB. Insulin-like growth factor I and insulin-like growth factor binding protein 5 in Crohn’s disease. Am J Physiol Gastrointest Liver Physiol 2001;280:G1022–G1029.PubMed

36.

McKaig BC, Hughes K, Tighe PJ, Mahida YR. Differential expression of TGF-b isoforms by normal and inflammatory bowel disease intestinal myofibroblasts. Am J Physiol Cell Physiol 2002;282:C172–C182.PubMed

37.

Pucilowska JB, McNaughton KK, Mohapatra NK, Hoyt EC, Zimmermann EM, Sartor RB et al. IGF-I and procollagen a1(I) are coexpressed in a subset of mesenchymal cells in active Crohn’s disease. Am J Physiol Gastrointest Liver Physiol 2000;279:G1307–G1322.PubMed

Title: TGF-β1 and IGF-1 and Anastomotic Recurrence of Crohn’s Disease After Ileo-Colonic Resection
Authors: Marco Scarpa
Marina Bortolami
Susan L. Morgan
Andromachi Kotsafti
Cesare Ruffolo
Renata D’Incà
Eugenia Bertin
Lino Polese
Davide F. D’Amico
Giacomo C. Sturniolo
Imerio Angriman
Publication date: 01-11-2008
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 11/2008
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-008-0641-5

2024 ASCO Annual Meeting

Springer Medicine

TGF-β1 and IGF-1 and Anastomotic Recurrence of Crohn’s Disease After Ileo-Colonic Resection

Abstract

Background

Patients and Methods

Results

Conclusion

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Background

Patients and Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2008

Surgical Outcomes of Patients with Gastrointestinal Stromal Tumors in the Era of Targeted Drug Therapy

Fluorophore-conjugated anti-CEA Antibody for the Intraoperative Imaging of Pancreatic and Colorectal Cancer

Mechanical Bowel Preparation in Intestinal Surgery: A Meta-Analysis and Review of the Literature

Surgical Management of Failed Endoscopic Treatment of Pancreatic Disease

Preoperative Liver Function Tests and Hemoglobin will Predict Complications Following Pancreaticoduodenectomy

Recent Trends of Hepatic Resection in Canada: 1995–2004